Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome.
作者信息
Meroni Pier Luigi, Tsokos George C
机构信息
Immunorheumatology Research Laboratory, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.
出版信息
Front Immunol. 2019 Feb 25;10:199. doi: 10.3389/fimmu.2019.00199. eCollection 2019.
Abstract
摘要
相似文献
1
Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome.社论：系统性红斑狼疮与抗磷脂综合征
Front Immunol. 2019 Feb 25;10:199. doi: 10.3389/fimmu.2019.00199. eCollection 2019.
2
[Systemic lupus erythematosus. Anti-phospholipid syndrome].[系统性红斑狼疮。抗磷脂综合征]
Rev Prat. 2008 Nov 15;58(17):1935-42.
3
[Item no 117: disseminated lupus erythematosus. Antiphospholipid syndrome].[项目编号117：播散性红斑狼疮。抗磷脂综合征]
Ann Dermatol Venereol. 2008 Nov;135(11 Suppl):F103-12. doi: 10.1016/j.annder.2008.07.024.
4
Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?抗磷脂综合征与系统性红斑狼疮：它们是独立的疾病实体，还是仅仅是同一范围内的临床表现？
Curr Opin Rheumatol. 2009 Sep;21(5):495-500. doi: 10.1097/BOR.0b013e32832effdd.
5
[Item no 117: disseminated lupus erythematosus. Antiphospholipid syndrome].
Ann Dermatol Venereol. 2005 Oct;132(10 Suppl):7S98-7S107.
6
Primary antiphospholipid syndrome (APS) or systemic lupus erythematosus related APS: from theory to practice.
J Rheumatol. 1994 Jul;21(7):1368-70.
7
Autoantibodies and other biomarkers - pathological consequences (1).自身抗体和其他生物标志物——病理后果(1)
Lupus. 2008 Mar;17(3):241-6. doi: 10.1177/0961203307088248.
8
Primary versus secondary antiphospholipid syndrome: is this lupus or not?
Curr Rheumatol Rep. 2004 Dec;6(6):445-50. doi: 10.1007/s11926-004-0023-2.
9
Systemic lupus erythematosus: An update for ophthalmologists.系统性红斑狼疮：眼科医生的最新资讯。
Surv Ophthalmol. 2016 Jan-Feb;61(1):65-82. doi: 10.1016/j.survophthal.2015.06.003. Epub 2015 Jul 18.
10
[Catastrophic antiphospholipid syndrome complicated by cardiogenic shock - a case report].[灾难性抗磷脂综合征合并心源性休克——一例报告]
Kardiol Pol. 2009 Jul;67(7):769-73.
引用本文的文献
1
Case Report: Remission of a patient with complex combination of autoimmune diseases by anti-CD19 CAR-T cell therapy.病例报告：抗CD19嵌合抗原受体T细胞疗法使一名患有复杂自身免疫病组合的患者病情缓解。
Front Immunol. 2025 Aug 21;16:1645304. doi: 10.3389/fimmu.2025.1645304. eCollection 2025.
2
Novel advances on pathophysiological mechanisms, clinical manifestations, and treatment of antiphospholipid syndrome.抗磷脂综合征的病理生理机制、临床表现及治疗方面的新进展。
Front Immunol. 2025 Aug 21;16:1639065. doi: 10.3389/fimmu.2025.1639065. eCollection 2025.
3
Antiphospholipid Antibodies as Key Players in Systemic Lupus Erythematosus: The Relationship with Cytokines and Immune Dysregulation.抗磷脂抗体在系统性红斑狼疮中的关键作用：与细胞因子和免疫失调的关系。
Int J Mol Sci. 2024 Oct 20;25(20):11281. doi: 10.3390/ijms252011281.
4
SAMD1 attenuates antiphospholipid syndrome-induced pregnancy complications.SAMD1 可减轻抗磷脂综合征引起的妊娠并发症。
Immun Inflamm Dis. 2023 Oct;11(10):e1006. doi: 10.1002/iid3.1006.
5
The Role of Neutrophil Extracellular Traps (NETs) in the Pathogenesis of Systemic Lupus Erythematosus and Antiphospholipid Syndrome.中性粒细胞胞外诱捕网（NETs）在系统性红斑狼疮和抗磷脂综合征发病机制中的作用。
Int J Mol Sci. 2023 Sep 1;24(17):13581. doi: 10.3390/ijms241713581.
6
HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease.缺氧诱导因子 1 调控狼疮皮肤病中的致病细胞毒性 T 细胞。
JCI Insight. 2023 Aug 22;8(16):e166076. doi: 10.1172/jci.insight.166076.
7
Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome.细胞焦亡触发的发病机制：抗磷脂综合征的新认识。
Front Immunol. 2023 Mar 31;14:1155222. doi: 10.3389/fimmu.2023.1155222. eCollection 2023.
8
SAMD1 attenuates antiphospholipid syndrome-induced vascular injury and pregnancy complications.SAMD1 可减轻抗磷脂综合征引起的血管损伤和妊娠并发症。
Immun Inflamm Dis. 2022 Sep;10(9):e678. doi: 10.1002/iid3.678.
9
Severe thoracic pyomyositis in a patient with systemic lupus erythematosus.系统性红斑狼疮患者的严重胸肌炎。
BMJ Case Rep. 2022 Mar 8;15(3):e246484. doi: 10.1136/bcr-2021-246484.
10
Laser Speckle Contrast Analysis: Functional Evaluation of Microvascular Damage in Connective Tissue Diseases. Is There Evidence of Correlations With Organ Involvement, Such as Pulmonary Damage?激光散斑对比分析：结缔组织病中微血管损伤的功能评估。是否有证据表明与器官受累（如肺损伤）存在相关性？
Front Physiol. 2021 Oct 11;12:710298. doi: 10.3389/fphys.2021.710298. eCollection 2021.
本文引用的文献
1
The evolution of drug discovery in systemic lupus erythematosus.系统性红斑狼疮药物研发的演进。
Nat Rev Rheumatol. 2015 Oct;11(10):616-20. doi: 10.1038/nrrheum.2015.86. Epub 2015 Jun 30.
2
IRF5 is associated with primary antiphospholipid syndrome, but is not a major risk factor.干扰素调节因子5与原发性抗磷脂综合征相关，但不是主要危险因素。
Arthritis Rheum. 2010 Apr;62(4):1201-2. doi: 10.1002/art.27345.
3
The interplay between the antiphospholipid syndrome and systemic lupus erythematosus.抗磷脂综合征与系统性红斑狼疮之间的相互作用。
Autoimmunity. 2009 May;42(4):257-9. doi: 10.1080/08916930902827918.
4
Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome.STAT4和BLK（而非BANK1或IRF5）与原发性抗磷脂综合征的关联。
Arthritis Rheum. 2009 Aug;60(8):2468-71. doi: 10.1002/art.24701.
5
Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?原发性抗磷脂综合征中的抗核小体抗体：系统性自身免疫的一个线索？
J Autoimmun. 2008 Feb-Mar;30(1-2):51-7. doi: 10.1016/j.jaut.2007.11.004.
Zotero 插件